SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

A sharp semiconductor selloff followed weak tech earnings and renewed doubts about whether massive AI-infrastructure spending will generate adequate returns. Traders debated whether the drop signals a deeper unwind or an oversold buying opportunity, with many watching technical support levels.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A strong third-quarter report and higher full-year revenue outlook, driven by Mounjaro and Zepbound demand, have pushed Lilly shares to record highs and fueled bullish analyst revisions. Some traders remain cautious about the rich valuation and lower profit guidance tied to acquisition-related charges, while Foundayos sales disappointed.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare add-on reimbursement could decline through 2027 has fueled concerns about pricing and CorMedixs largest revenue driver. Traders disagree on the significance: some see DaVitas outlook as preliminary and point to CMS estimates, while others worry about sustained reimbursement pressure and criticize managements communication.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has put pressure on Precigens PAPZIMEOS, sparking debate over whether the new entrant will take market share. Traders are weighing that competitive threat against Precigens first-mover advantage and established commercial launch, with some viewing the selloff as an overreaction.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs upcoming decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders focusing on the revised upper-limb indication and HOPE-3 extension data. Some see recent commercial hiring and the FDAs rare-disease focus as encouraging signs, while others point to prior regulatory setbacks and uncertainty over the evidence; rumors of leaks and short covering remain speculation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A run to a 52-week high ahead of expected Q3 results has traders focused on BRIUMVI sales and guidance, while debating whether the move reflects earnings expectations or unconfirmed buyout speculation; high short interest is also fueling short-squeeze talk.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Power and Energy, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Power and Energy segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925, and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillars sharp selloff following its third-quarter results dominates discussion: despite an earnings beat and record backlog, the company left its full-year outlook unchanged, prompting concerns that growth and data-center demand may not meet lofty expectations. Traders are split between expecting further downside and buying the dip, pointing to the backlog and continued demand for power-generation equipment as reasons for optimism.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

XLK is under pressure amid a tech-sector selloff, with traders linking the move to concerns about AI financing after reports that Anthropic could receive a speculative-grade credit rating. The community is divided between viewing this as a broader correction and rotation out of tech and treating the AI-credit narrative as a trigger or an overreaction; some still see a potential rebound.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is drawing attention around its latest monthly distribution as Nasdaq weakness weighs on the fund. Some investors see the pullback as a chance to add for income, while others note that its covered-call strategy can soften declines but does not prevent losses and may limit upside in a rebound.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas selection to join the S&P 500 is the main catalyst, with traders anticipating buying from index-tracking funds. Some are bullish on the inclusion while others warn of a possible sell-the-news reaction; bearish sentiment and options-flow chatter add to the debate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


hutthaibinh

Hút Bể Phốt Tại Thái Bình